Vedolizumab in Crohn’s disease with rectal fistulas and presacral abscess: A case report

doi:10.3748/wjg.v27.i5.442

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5646)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series.

Item

Count

PDF

407

WORD

186

HTML

2533

Figures (1-5)

345

Sum=3471

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

377

Download

675

Sum=1052

Publishing Process of This Article

Item

Count

Browse

395

Download

728

Sum=1123

Feb 7, 2021 (publication date) through May 7, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Feb 7, 2021; 27(5): 442-448
Published online Feb 7, 2021. doi: 10.3748/wjg.v27.i5.442

Full Size Figure Download Figure

Figure 5 Magnetic resonance imaging seven months after diagnosis. A: No more rectal fistula tract; B: No more presacral abscess.

Citation: Yeh H, Kuo CJ, Wu RC, Chen CM, Tsai WS, Su MY, Chiu CT, Le PH. Vedolizumab in Crohn’s disease with rectal fistulas and presacral abscess: A case report. World J Gastroenterol 2021; 27(5): 442-448
URL: https://www.wjgnet.com/1007-9327/full/v27/i5/442.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i5.442